Detalhe da pesquisa
1.
Targeting novel inhibitory receptors in cancer immunotherapy.
Semin Immunol
; 49: 101436, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33288379
2.
CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease.
PLoS Biol
; 12(4): e1001833, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24714093
3.
HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.
J Immunol
; 188(5): 2102-10, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22291187
4.
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1.
Nat Med
; 28(3): 545-556, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35228752
5.
Tim-3 mediates T cell trogocytosis to limit antitumor immunity.
J Clin Invest
; 132(9)2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316223
6.
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.
Science
; 371(6529): 595-602, 2021 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33542131
7.
Reduced frequency of regulatory T cells in peripheral blood stem cell compared to bone marrow transplantations.
Biol Blood Marrow Transplant
; 16(3): 430-4, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19883775
8.
TIGIT in cancer immunotherapy.
J Immunother Cancer
; 8(2)2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32900861
9.
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.
Clin Cancer Res
; 26(20): 5520-5533, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591463
10.
IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell.
Cancer Immunol Res
; 7(8): 1258-1266, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31239318
11.
CD226 opposes TIGIT to disrupt Tregs in melanoma.
JCI Insight
; 3(14)2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30046006
12.
Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma.
J Clin Oncol
; : JCO1800632, 2018 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30359157
13.
IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells.
Cancer Res
; 75(8): 1635-44, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25720800
14.
TIGIT and PD-1 impair tumor antigen-specific CD8⺠T cells in melanoma patients.
J Clin Invest
; 125(5): 2046-58, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25866972
15.
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8⺠T cells induced by melanoma vaccines.
Cancer Res
; 74(4): 1045-55, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24343228